The clinical and economic analysis of pharmaceutical provision of patients with depressive disorders in hospital environment
DOI:
https://doi.org/10.24959/cphj.16.1391Keywords:
depression, clinical and economic analysis, pharmaceutical provision of patients with depressive disordersAbstract
The results of the clinical and economic analysis of pharmaceutical provision of patients with depressive disorders in the departments of the specialized healthcare institution in 2015 are presented. It has been found that drugs for the pathogenetic treatment of depression account for the greatest number of medical prescriptions in the structure of drug consumption. Thus, according to the results of studies the greatest number of prescriptions and the highest amount of drug consumption are per three antidepressants. More than half of the resource has been spent on consumption of drugs that are essential by the requirements of the regulatory framework regulating the issues of medical care to patients with depressive disorders. Taking into account the fact that a significant number of the patients who underwent inpatient treatment had a recurrent nature of the disease further pharmacoepidemiological studies of the drug consumption should be expedient, namely determination of the rationality of prescribing drugs with the antidepressant action using the ATC-DDD methodology.
References
Авксентьева М.В., Воробьев П.А., Герасимов В.Б. и др. Экономическая оценка эффективности лекарственной терапии (фармакоэкономический анализ) / Под ред. проф. П.А.Воробьева. – М.: Ньюдиамед, 2000. – 80 с.
Бездітко Н.В. // Укр. вісник психоневрол. – 2013. – Т. 21, №4 (77). – С. 123-129.
Мищенко О.Я., Адонкина В.Ю., Чинуш И.В. // Фармац. журн. (Узбекистан). – 2013. – №1. – С. 4-9.
Немченко А.С., Яковлева О.С. // Управління, економіка та забезпечення якості в фармації. – 2011. – №5 (19). – С. 52-57.
Панфілова Г.Л., Цурікова О.В. // Запорізький мед. журн. – 2014. – №1. – С. 35-39.
Скрипніков А.М., Гринь К.В. // Вісник ВДНЗУ «Українська медична стоматологічна академія». – 2013. – №2 (42). – С. 156-158.
Яковлєва Л.В., Бездітко Н.В., Герасимова О.О. та ін. Фармакоекономіка. – Вінниця: Нова книга, 2009. – 208 с.
Drummond M.F., Schwartz J.S., Jönsson B. et al. // Int. J. Technol. Assess. Health Care. – 2008. – Vol. 24 (3). – P. 244-258.
Rascati K.L. Essentials of Pharmacoeconomics – Lippincott Williams & Wilkins, 2013. – 310 р.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
